Copyright
©The Author(s) 2022.
World J Crit Care Med. Nov 9, 2022; 11(6): 387-389
Published online Nov 9, 2022. doi: 10.5492/wjccm.v11.i6.387
Published online Nov 9, 2022. doi: 10.5492/wjccm.v11.i6.387
Table 2 Inflammatory markers in coronavirus disease 2019 survivors and non-survivors
| Non-survivors (n = 167) | Survivors (n = 94) | P value | |
| IL-6 day 1 (pg/mL) | 116 (33, 410) | 72 (45, 210) | 0.75 |
| IL-6 day 2 | 470 (36, 1299) | 153 (10, 280) | 0.38 |
| D-Dimer day 1 (ng/mL) | 855 (522, 2434) | 595 (337, 1349) | 0.013 |
| D-Dimer day 2 | 691 (436, 1743) | 1040 (550, 3431) | 0.11 |
| CRP day 1 (mg/L) | 125 (61, 179) | 130 (89, 185) | 0.55 |
| CRP day 2 | 116 (82, 185) | 119 (47, 175) | 0.29 |
| Ferritin day 1 (ng/mL) | 869 (406, 1467) | 995 (488, 1571) | 0.35 |
| Ferritin day 2 | 822 (447, 1432) | 1053 (712, 2057) | 0.05 |
- Citation: Iglesias JI, Vassallo AV. Correction to “Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital” . World J Crit Care Med 2022; 11(6): 387-389
- URL: https://www.wjgnet.com/2220-3141/full/v11/i6/387.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v11.i6.387